Myriad Genetics Earlier Said Expecting Q4 Adj. EPS $0.40-$0.42 vs $0.49 Est., Sales $187M-$189M vs $200M Est.; Cuts FY15 EPS Guidance from $1.50-$1.55 to $1.44-$1.46, Sales from $730M-$740M to $720M-$722M vs $734M Est.